Allopurinol

CHEMBL1467 Phase 4 Zugelassen Small molecule
Half-Life
1-2 hours
Bioavailability
Protein Binding
Molecular Weight
136.1 g/mol
LogP
-0.7
Phase
4

A xanthine oxidase inhibitor that reduces the production of uric acid in the body, used primarily to prevent gout attacks and kidney stones caused by uric acid crystal buildup in joints and the urinary tract. It is also used to prevent elevated uric acid levels during cancer treatment when chemotherapy causes rapid breakdown of cancer cells.

Molekularmasse

136,1120 g/mol

LogP

-0,70

TPSA

70,10 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Arzneimittelklassen

Wirkmechanismus

Xanthine oxidase inhibitor reducing uric acid production.

Pharmacokinetics (PK)

Half-Life 1-2 hours

Pharmacodynamics (PD)

Mechanismus

Xanthine oxidase inhibitor reducing uric acid production.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Oc1ncnc2[nH]ncc12

InChI

InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)

Molecular Formula

C5H4N4O

HBD / HBA

2 / 3

Rotierbare Bindungen

0

Schwere Atome

10

Primary Target

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A xanthine oxidase inhibitor that reduces the production of uric acid in the body, used primarily to prevent gout attacks and kidney stones caused by uric acid crystal buildup in joints and the urinary tract. It is also used to prevent elevated uric acid levels during cancer treatment when chemotherapy causes rapid breakdown of cancer cells.

Xanthine oxidase inhibitor reducing uric acid production.

Key pharmacokinetic parameters for Allopurinol: Half-life: 1-2 hours.

Yes, Allopurinol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1467. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135401907. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.